Lost password ?
Gulf Pharmaceutical
JULPHAR, POISED FOR A COMEBACK
Nov 03 - Gulf Pharmaceutical (Buy, UAE)’s share recommendation moved from Reduce in early this year to a current Buy, backed by an important upside potential of 39.7% while our last short paper of April was ...
Executive summary
Conflict of Interest
Pages 43
Language English
Publish on November 3, 2025
€ 500
VAT Exl.
You might be also interested by these reports :
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.